# Annovis Bio, Inc.: Form DEF 14A, filed Sep 11, 2026

- Company: [Annovis Bio, Inc.](/companies/anvs.md) (CIK 1477845)
- Form: DEF 14A
- Filed: 2026-09-11
- Accepted by EDGAR: Sep 11, 2026, 16:53 ET
- Period: 2026-10-14
- Accession: 0001104659-26-107113
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1477845/000110465926107113/tm2623911-2_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1477845/000110465926107113/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1477845/000110465926107113/tm2623911-2_def14a.htm

Filed Sep 11, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-107113. Last ingested by Listed: Nov 14, 2026, 21:17 ET. No prices; not investment advice.
